Azithromycin maintains barrier integrity in a cell model of ventilator induced lung injury
J. Joelsson (Reykjavik, Iceland), I. Myszor (Reykjavik, Iceland), S. Sigurdsson (Reykjavik, Iceland), F. Lehmann (Reykjavik, Iceland), C. Page (London, United Kingdom), G. Gudmundsson (Reykjavik, Iceland), T. Gudjonsson (Reykjavik, Iceland), S. Karason (Reykjavik, Iceland)
Source: Virtual Congress 2020 – Translational therapeutic advances
Session: Translational therapeutic advances
Session type: E-poster session
Number: 3351
Disease area: Respiratory critical care
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Joelsson (Reykjavik, Iceland), I. Myszor (Reykjavik, Iceland), S. Sigurdsson (Reykjavik, Iceland), F. Lehmann (Reykjavik, Iceland), C. Page (London, United Kingdom), G. Gudmundsson (Reykjavik, Iceland), T. Gudjonsson (Reykjavik, Iceland), S. Karason (Reykjavik, Iceland). Azithromycin maintains barrier integrity in a cell model of ventilator induced lung injury. 3351
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: